Eva Pålsson-McDermott and Luke O’Neill at Trinity University Dublin discuss targeting immunometabolism being an anti-inflammation tactic. They very first critique metabolic therapies with anti-inflammatory consequences, after which you can target glycolysis and the TCA cycle to show the strategy of focusing on metabolic intermediates and enzymes in inflammation.7 Moreover immunometabo... https://directivepublications.org/journal-of-immunology/